Cognition Therapeutics, Inc.

NASDAQ:CGTX

2.61 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -33.971-25.788-21.397-11.716-7.839-4.842
Depreciation & Amortization 0.2660.2520.2350.0930.0980.081
Deferred Income Tax 00-6.54-0.41600.238
Stock Based Compensation 3.7484.3543.5725.1830.4750
Change In Working Capital 1.2884.846-0.9432.8423.0670.57
Accounts Receivables -1.4052.391-1.406-1.1143.001-1.118
Inventory 001.4061.114-3.0011.118
Accounts Payables 00-1.0922.165-0.3640.862
Other Working Capital 2.6932.4551.5551.7910.43-0.292
Other Non Cash Items 0.1950.3186.540.3830.7660.855
Operating Cash Flow -28.474-16.018-18.533-3.631-3.433-3.098
Investing Activities:
Investments In Property Plant And Equipment -0.004-0.147-0.171-0.027-0.01-0.144
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -0.004-0.147-0.171-0.027-0.01-0.144
Financing Activities:
Debt Repayment -0.739-0.811-1.396-0.2685.8112.828
Common Stock Issued 24.355.3325.32444.2170.0470
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -0.04601.6189.252-0.093-0.034
Financing Cash Flow 23.5654.5215.54653.2015.7652.794
Other Information:
Effect Of Forex Changes On Cash 00.004-0.001-0.011-0.023-0.06
Net Change In Cash -4.913-11.64-13.15949.5322.299-0.508
Cash At End Of Period 25.00929.92241.56254.7215.1892.89